Lyme Vaccine Hope After Decades | Canada News

Lyme disease cases in Canada have surged from 144 in 2009 to over 7,000 in preliminary 2025 data—driving a renewed push for vaccines after the controversial withdrawal of LYMErix in 2002. Pfizer and Valneva’s new vaccine shows 70% efficacy with four doses, targeting bacteria before they spread, while Moderna develops alternatives. But hurdles remain: cost, dosing frequency, and public trust—echoing past failures—could block widespread use. Until then, prevention remains key: wear gear, repel ticks, and remove them within 24 hours to avoid infection. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d55eff1384412b4b